A migraine drug which has been hailed as ‘life changing’ by some users has been approved for use by the NHS in Scotland.
Benefits
Patients are set to benefit from the drug after the Scottish Medicine Consortium (SMC) accepted Fremanezumab. The SMC has taken into account the benefits of a confidential discount that they said improved the cost-effectiveness of the drug which is produced by Teva Pharmaceuticals.
Please register or login to comment!
Register now Login